cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Verastem Inc
16 own
43 watching
Current Price
$0.71
$0.01
(0.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
148.15M
52-Week High
52-Week High
2.13
52-Week Low
52-Week Low
0.2895
Average Volume
Average Volume
0.69M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization148.15M
icon52-Week High2.13
icon52-Week Low0.2895
iconAverage Volume0.69M
iconDividend Yield--
iconP/E Ratio--
What does the Verastem Inc do?
Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing drugs targeting cancer stem cells (CSCs). Its programs target the focal adhesion kinase (FAK) and the PI3K/mTOR signaling pathways. The company's product candidate FAK inhibitor, VS-6063, is in Phase 1 study in combination with PD-1 inhibitor pembrolizumab and gemcitabine for pancreatic cancer; a Phase Ib clinical trial in combination with paclitaxel for patients with ovarian cancer; a Phase II study in patients with non-small cell lung cancer; a Phase II trial preceding surgery in mesothelioma; and a Phase 1/1b clinical trail in combination with avelumab in patients with ovarian cancer, as well as a combination trial of VS-6063 and VS-5584 in patients with relapsed mesothelioma. It is also developing FAK inhibitor, VS-4718 that is in Phase 1, single-agent, dose escalation trial in patients with advanced cancers; and a Phase 1, dose-escalation clinical trial in combination with gemcitabine and nab-paclitaxel in patients with advanced solid tumors, as well as a Phase 1, dose-escalation clinical trial of PI3K/mTORC1/2 inhibitor, VS-5584, in patients with advanced non-hematologic malignancies or lymphoma. The company has license agreement with Whitehead Institute for Biomedical Research; The Scripps Research Institute; and Pfizer, Inc. Verastem, Inc. was founded in 2010 and is based in Needham, Massachusetts.
Read More
How much money does Verastem Inc make?
News & Events about Verastem Inc.
Ticker Report
2 months ago
StockNews.com started coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a research note published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other equities research analysts have also recently weighed in on the ...
Zolmax
2 months ago
StockNews.com started coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a research note published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other equities research analysts have also recently weighed in on the stock. HC ...
Ticker Report
5 months ago
Principal Financial Group Inc. lowered its stake in shares of Verastem, Inc. (NASDAQ:VSTM Get Rating) by 27.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 200,197 shares of the biopharmaceutical companys stock after selling 74,...
Zolmax
6 months ago
Verastem, Inc. (NASDAQ:VSTM Get Rating) saw a large decline in short interest in the month of June. As of June 30th, there was short interest totalling 4,850,000 shares, a decline of 40.6% from the June 15th total of 8,160,000 shares. Based on an average daily volume of 2,460,000 shares, the days-to...
Frequently Asked Questions
Frequently Asked Questions
What is Verastem Inc share price today?
plus_minus_icon
Can Indians buy Verastem Inc shares?
plus_minus_icon
How can I buy Verastem Inc shares from India?
plus_minus_icon
Can Fractional shares of Verastem Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Verastem Inc stocks?
plus_minus_icon
What is today’s traded volume of Verastem Inc?
plus_minus_icon
What is today’s market capitalisation of Verastem Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Verastem Inc?
plus_minus_icon
What percentage is Verastem Inc down from its 52-Week High?
plus_minus_icon
What percentage is Verastem Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.71
$0.01
(0.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00